Pathania Sucheta, Rudramurthy Shivaparkash M, Narang Tarun, Saikia Uma N, Dogra Sunil
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):678-684. doi: 10.4103/ijdvl.IJDVL_645_17.
Recurrent and clinically unresponsive dermatophytosis is being increasingly encountered in our country. It runs a protracted course with exacerbations and remissions. However, there is little information regarding the extent of the problem and the characteristics of recurrent dermatophytosis in published literature.
We sought to determine the prevalence, risk factors and clinical patterns of recurrent dermatophytosis in our institution. We also investigated the causative dermatophyte species and antifungal susceptibility patterns in these species.
One hundred and fifty patients with recurrent dermatophytosis attending the outpatient department of the Postgraduate Institute of Medical Education and Research, Chandigarh, India were enrolled in the study conducted from January 2015 to December 2015. A detailed history was obtained in all patients, who were then subjected to a clinical examination and investigations including a wet preparation for direct microscopic examination, fungal culture and antifungal susceptibility tests.
Recurrent dermatophytosis was seen in 9.3% of all patients with dermatophytosis in our study. Trichophyton mentagrophytes was the most common species identified (36 patients, 40%) samples followed by T. rubrum (29 patients, 32.2%). In-vitro antifungal susceptibility testing showed that the range of minimum inhibitory concentrations (MIC) on was lowest for itraconazole (0.015-1), followed by terbinafine (0.015-16), fluconazole (0.03-32) and griseofulvin (0.5-128) in increasing order.
A limitation of this study was the absence of a suitable control group (eg. patients with first episode of typical tinea).
Recurrence of dermatophytosis was not explainable on the basis of a high (MIC) alone. Misuse of topical corticosteroids, a high number of familial contacts, poor compliance to treatment over periods of years, and various host factors, seem to have all contributed to this outbreak of dermatophytosis in India.
在我国,复发性且临床上无反应的皮肤癣菌病越来越常见。其病程迁延,有加重和缓解期。然而,已发表的文献中关于该问题的严重程度及复发性皮肤癣菌病特征的信息很少。
我们试图确定我院复发性皮肤癣菌病的患病率、危险因素及临床模式。我们还调查了致病皮肤癣菌种类及其抗真菌药敏模式。
2015年1月至2015年12月,在印度昌迪加尔医学教育与研究研究生院门诊部就诊的150例复发性皮肤癣菌病患者纳入本研究。所有患者均获得详细病史,随后接受临床检查及包括直接显微镜检查的湿片法、真菌培养和抗真菌药敏试验等检查。
在我们的研究中,所有皮肤癣菌病患者中有9.3%出现复发性皮肤癣菌病。鉴定出的最常见菌种是须癣毛癣菌(36例患者,40%),其次是红色毛癣菌(29例患者,32.2%)。体外抗真菌药敏试验表明,伊曲康唑的最低抑菌浓度(MIC)范围最低(0.015 - 1),其次是特比萘芬(0.015 - 16)、氟康唑(0.03 - 32)和灰黄霉素(0.5 - 128),呈递增顺序。
本研究的一个局限性是缺乏合适的对照组(例如,首次发作的典型癣患者)。
仅根据高最低抑菌浓度无法解释皮肤癣菌病的复发。局部皮质类固醇的滥用、大量家庭接触者、多年来治疗依从性差以及各种宿主因素,似乎都促成了印度此次皮肤癣菌病的暴发。